1) Stonegate made continued progress in three key areas of focus; core earnings stability; liquidity position and debt management.
2) benefit greatly from increased originations this quarter. GAAP net income of $15.6 million or $0.60 per diluted share in the third quarter.Our third quarter adjusted net income was $11 million or $0.42 per diluted share, after adjusting for the fair market value change in MSRs and stock-based compensation expense
3) we increased our book value by nearly $16 million during the quarter to $223.6 million or $8.65 per share as of September 30.
4)reduced our MSR debt by another $4.3 million during the quarter, while maintaining an adequate liquidity position
5)revenues were up 35%, with all channels posting increases
6)we leveraged our existing expense base and controlled fixed cost...decreasing total servicing expenses by 4%
7) We were able to reverse $6.2 million of our valuation allowance this quarter, favorably impacting our income tax expense.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM